Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06111014 |
| Consolidated Lead Sponsor | Alector |
| Therapeutic Condition Cohort | Rare Genetic, Women's Health, and Other |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 17 participants (ACTUAL) |
| Registered Start Date | 2023-12-08 |
| WhyStopped Classification | Unspecified |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| University of Pennsylvania Abramson Cancer Center | Philadelphia, PA | Open Hospital Dossier -> |
| UZ Leuven | Leuven, Belgium | Open Hospital Dossier -> |
| Sunnybrook Health Sciences Centre | Toronto, Canada | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.